Johnson & Johnson and Bristol Myers Squibb Co. are urging the US Supreme Court to review a Biden-era program that allows Medicare to negotiate drug prices with pharmaceutical giants. The drugmakers ...
An estimated one and a half million people were newly diagnosed with HIV in 2024. But a facility in Richmond hopes to see those numbers drop even more. A partnership between Virginia Commonwealth ...
ZIM Integrated Shipping Services (ZIM) rose 13% in after-hours trading after saying it received proposals from multiple strategic parties during its review of strategic alternatives. ZIM said the ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — A new program ...
WASHINGTON, Dec 18 (Reuters) - U.S. President Donald Trump's administration has launched a review that could result in the first shipments to China of Nvidia's second-most powerful AI chips, five ...
The University of Alabama at Birmingham will update its holistic admissions review process with phased changes to the university’s test optional policy. The first phase will apply to first year ...
Warner Bros. Discovery CEO David Zaslav said Wednesday that the regulatory review of Warner’s deal with Netflix has begun, even as Paramount mounts a hostile takeover bid. Two senators are now coming ...
Following submission on June 16, the NDA was accepted for review as a “complete class 2 response” by the FDA on July 16, 2025, with a target PDUFA action date of December 16. Also Read: FDA Rejects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback